Mioflazine (di(hydrochloride) hydrate)

Cat. No.: HY-U00049A: FAQs
Data Sheet Handling Instructions

Molarity Calculator

Mioflazine dihydrochloride hydrate is a nucleoside transport inhibitor with sleep-improving activity. Mioflazine dihydrochloride hydrate helps maintain the mechanical function of the left ventricle and significantly improves the heart's recovery ability after global ischemia at new temperatures. The application of Mioflazine dihydrochloride hydrate has shown that it has an important protective effect on recovery after cardiac injury.

For research use only. We do not sell to patients.

Mioflazine (di(hydrochloride) hydrate) Chemical Structure

CAS No. : 79467-24-6

Size		Stock
MOQ		Minimum order quantity
50 mg		Get quote
100 mg		Get quote
250 mg		Get quote
Other size		Get quote

Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of Mioflazine (di(hydrochloride) hydrate):

Mioflazine Get quote
Mioflazine di(hydrochloride) Get quote

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	Mioflazine dihydrochloride hydrate is a nucleoside transport inhibitor with sleep-improving activity. Mioflazine dihydrochloride hydrate helps maintain the mechanical function of the left ventricle and significantly improves the heart's recovery ability after global ischemia at new temperatures. The application of Mioflazine dihydrochloride hydrate has shown that it has an important protective effect on recovery after cardiac injury^[1].
Molecular Weight	666.41
Formula	C₂₉H₃₄Cl₄F₂N₄O₃
CAS No.	79467-24-6
SMILES	O=C(C1N(CCCC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)CCN(C1)CC(NC4=C(Cl)C=CC=C4Cl)=O)N.Cl.Cl.O
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation	Data Sheet (267 KB) Handling Instructions (2659 KB)
References	[1]. Wauquier A, et al. Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitor. Psychopharmacology (Berl). 1987;91(4):434-9. [Content Brief] [2]. Mioflazine, a potentially protective drug against ischaemic damage: a study in dogs [Content Brief] [3]. Pirovano IM, et al. Inhibition of nucleoside uptake in human erythrocytes by a new series of compounds related to lidoflazine and mioflazine. Eur J Pharmacol. 1990 Dec 15;189(6):419-22. [Content Brief]